Clinical Trial

Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

Study acronym: MS-GDI
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT06516458
Lead Sponsor Shirley Ryan AbilityLab
Conditions Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis, Relapsing-Remitting
Enrollment 40 participants
Start Date 2024-07
Primary Completion 2025-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-07-24